These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12008721)

  • 1. Medicare is likely to pay for anticancer drugs.
    Charatan F
    BMJ; 2002 May; 324(7346):1118. PubMed ID: 12008721
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicare cost containment strategy targets several oncology drugs.
    Twombly R
    J Natl Cancer Inst; 2004 Sep; 96(17):1268-70. PubMed ID: 15339960
    [No Abstract]   [Full Text] [Related]  

  • 3. Realigning incentives for developing and pricing new anticancer treatments.
    Howard DH
    JAMA; 2011 Jun; 305(22):2347-8. PubMed ID: 21642689
    [No Abstract]   [Full Text] [Related]  

  • 4. New Math on Drug Cost-Effectiveness.
    Bach PB
    N Engl J Med; 2015 Nov; 373(19):1797-9. PubMed ID: 26535510
    [No Abstract]   [Full Text] [Related]  

  • 5. Product director clarifies point about Medicare coverage of oral anticancer drugs.
    Kaiser GM
    ONS News; 2005 Apr; 20(4):3; author reply 3. PubMed ID: 15862044
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating off-label uses of anticancer drugs: time for a change.
    Sox HC
    Ann Intern Med; 2009 Mar; 150(5):353-4. PubMed ID: 19221369
    [No Abstract]   [Full Text] [Related]  

  • 7. Rising Cost of Anticancer Medications in the United States.
    Jackson K; Nahata MC
    Ann Pharmacother; 2017 Aug; 51(8):706-710. PubMed ID: 28707550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A real-world analysis of cancer drug wastage due to oversized vials.
    Liran O; Prus J; Gordon N; Almog V; Gruenewald T; Goldstein DA
    J Am Pharm Assoc (2003); 2018; 58(6):643-646. PubMed ID: 30017368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Anticancer Drugs Associated With Large Increases In Costs And Life Expectancy.
    Howard DH; Chernew ME; Abdelgawad T; Smith GL; Sollano J; Grabowski DC
    Health Aff (Millwood); 2016 Sep; 35(9):1581-7. PubMed ID: 27605636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When patients cannot afford their medications.
    Tseng CW
    Am Fam Physician; 2004 Aug; 70(3):605-6, 608. PubMed ID: 15317446
    [No Abstract]   [Full Text] [Related]  

  • 11. The costs of making practice more cost-effective.
    Weeks WB; Wallace AE
    JAMA; 2002 Apr; 287(13):1648; author reply 1649-50. PubMed ID: 11926883
    [No Abstract]   [Full Text] [Related]  

  • 12. Does reimbursement influence chemotherapy treatment for cancer patients?
    Jacobson M; O'Malley AJ; Earle CC; Pakes J; Gaccione P; Newhouse JP
    Health Aff (Millwood); 2006; 25(2):437-43. PubMed ID: 16522584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are we ready to ration psychiatric medications?
    Glazer WM
    Psychiatr Serv; 2004 Jun; 55(6):611. PubMed ID: 15175454
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant erythropoietin and Medicare payment.
    Eggers PW
    JAMA; 1991 Nov; 266(19):2705-6. PubMed ID: 1942420
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of medicare reimbursement policies on the cost and setting of cancer chemotherapy.
    Cowan DH
    Cancer Invest; 1996; 14(2):184-6. PubMed ID: 8597906
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost sharing, caps on benefits, and the chronically ill--a policy mismatch.
    Thorpe KE
    N Engl J Med; 2006 Jun; 354(22):2385-6. PubMed ID: 16738277
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost of being excluded: impact of excluded medications under Medicare part D on nursing home residents.
    Stefanacci RG
    J Am Med Dir Assoc; 2005; 6(6):415-20. PubMed ID: 16286068
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare drug expansion causes controversy in the USA.
    Bristol N
    Lancet; 2009 Feb; 373(9663):532. PubMed ID: 19230076
    [No Abstract]   [Full Text] [Related]  

  • 19. Unintended consequences of caps on Medicare drug benefits.
    Hsu J; Price M; Huang J; Brand R; Fung V; Hui R; Fireman B; Newhouse JP; Selby JV
    N Engl J Med; 2006 Jun; 354(22):2349-59. PubMed ID: 16738271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?
    Mason A; Drummond M; Ramsey S; Campbell J; Raisch D
    J Clin Oncol; 2010 Jul; 28(20):3234-8. PubMed ID: 20498408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.